Cooperative STAT/NF-κB signaling regulates lymphoma metabolic reprogramming and aberrant GOT2 expression.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 29666362.
- Also identified by DOI 10.1038/s41467-018-03803-x and PMC identifier 5904148.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Knowledge of stromal factors that have a role in the transcriptional regulation of metabolic pathways aside from c-Myc is fundamental to improvements in lymphoma therapy. Using a MYC-inducible human B-cell line, we observed the cooperative activation of STAT3 and NF-κB by IL10 and CpG stimulation. We show that IL10 + CpG-mediated cell proliferation of MYC<sup>low</sup> cells depends on glutaminolysis. By <sup>13</sup>C- and <sup>15</sup>N-tracing of glutamine metabolism and metabolite rescue experiments, we demonstrate that GOT2 provides aspartate and nucleotides to cells with activated or aberrant Jak/STAT and NF-κB signaling. A model of GOT2 transcriptional regulation is proposed, in which the cooperative phosphorylation of STAT3 and direct joint binding of STAT3 and p65/NF-κB to the proximal GOT2 promoter are important. Furthermore, high aberrant GOT2 expression is prognostic in diffuse large B-cell lymphoma underscoring the current findings and importance of stromal factors in lymphoma biology.
Medical subject headings
- Aspartate Aminotransferase, Mitochondrial
- Gene Expression Regulation, Neoplastic
- Lymphoma, Large B-Cell, Diffuse
- STAT3 Transcription Factor
- Transcription Factor RelA